AHNAK2 is a potential prognostic biomarker in patients with PDAC

Title
AHNAK2 is a potential prognostic biomarker in patients with PDAC
Authors
Keywords
AHNAK2, pancreatic ductal adenocarcinoma, overall survival, prognostic factor, nomogram
Journal
Oncotarget
Volume 8, Issue 19, Pages -
Publisher
Impact Journals, LLC
Online
2017-03-09
DOI
10.18632/oncotarget.15990

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now